Collegium Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	239.99	176.24	188.97	176.66	170.02	146.63	118.79	153.32	95.79	1.71	Upgrade
Short-Term Investments	71.6	0	0	0	0	0	0	0	0	0	Upgrade
Cash & Cash Equivalents	311.6	176.24	188.97	176.66	170.02	146.63	118.79	153.32	95.79	1.71	Upgrade
Cash Growth	76.81%	-6.74%	6.97%	3.91%	15.95%	23.43%	-22.52%	60.05%	5488.91%	-77.54%	Upgrade
Receivables	179.53	183.12	105.84	83.32	72.95	77.95	9.97	2.13	0	0	Upgrade
Inventory	32.33	46.5	17.39	15.61	9.64	7.82	1.81	1.32	0	0	Upgrade
Other Current Assets	14.15	14.13	3.33	2.29	3.11	5.12	2.91	1.81	1.09	2.78	Upgrade
Total Current Assets	537.6	419.99	315.54	277.89	255.72	237.51	133.48	158.58	96.88	4.5	Upgrade
Property, Plant & Equipment	22.01	26.38	27.14	27.38	20.9	9.27	1.83	1.04	0.74	0.51	Upgrade
Goodwill and Intangibles	555.57	701.16	268.72	335.9	29.5	44.26	0	2.1	0	0	Upgrade
Other Long-Term Assets	28.13	26.6	80.68	2.67	0.18	0.2	0.26	0.3	0.1	0.08	Upgrade
Total Long-Term Assets	605.71	754.14	376.53	365.95	50.58	53.73	2.08	3.44	0.84	0.59	Upgrade
Total Assets	1,143	1,174	692.08	643.84	306.3	291.25	135.57	162.02	97.72	5.09	Upgrade
Accounts Payable	8.69	3.49	4.19	10.02	6.25	12.15	5.68	9.11	3.54	2.21	Upgrade
Deferred Revenue	0	0	0	0	0	0	0	4.94	0	0	Upgrade
Current Debt	184.32	163.61	49.17	48.23	4.49	1.64	1.48	2.67	2.67	6.25	Upgrade
Other Current Liabilities	264.9	266.62	226.21	181.21	191.03	175.33	24.33	8.88	2.23	1.96	Upgrade
Total Current Liabilities	457.92	433.73	279.57	239.45	201.77	189.13	31.49	25.6	8.43	10.42	Upgrade
Long-Term Debt	489.96	545.56	209.58	218.36	17.11	9.86	0	1.48	4.15	6.81	Upgrade
Other Long-Term Liabilities	0	0	0	0	0	0.68	0	0.03	0.07	0.1	Upgrade
Total Long-Term Liabilities	489.96	545.56	209.58	218.36	17.11	10.53	0	1.51	4.21	6.91	Upgrade
Total Liabilities	947.88	979.29	489.15	457.81	218.87	199.66	31.49	27.11	12.65	17.33	Upgrade
Total Debt	674.28	709.18	258.75	266.58	21.59	11.5	1.48	4.15	6.81	13.07	Upgrade
Debt Growth	-4.92%	174.08%	-2.94%	1134.53%	87.77%	677.55%	-64.33%	-39.15%	-47.86%	1171.01%	Upgrade
Retained Earnings	-233.19	-281.34	-256.34	-333.15	-359.9	-337.18	-298.05	-223.18	-129.01	-101.75	Upgrade
Comprehensive Income	0.01	0	0	0	0	0	0	0	0	0	Upgrade
Shareholders' Equity	195.43	194.84	202.93	186.03	87.43	91.59	104.08	134.91	85.07	-89.35	Upgrade
Net Cash / Debt	-362.69	-532.94	-69.78	-89.92	148.43	135.13	117.32	149.18	88.98	-11.35	Upgrade
Net Cash / Debt Growth	-	-	-	-	9.84%	15.19%	-21.36%	67.65%	-	-	Upgrade
Net Cash Per Share	-8.68	-15.75	-1.70	-2.56	4.44	4.10	3.88	6.15	6.57	-12.15	Upgrade
Working Capital	79.69	-13.74	35.98	38.44	53.96	48.39	102	132.98	88.45	-5.92	Upgrade
Book Value Per Share	5.79	5.76	5.81	5.41	2.61	2.78	3.44	5.56	6.28	-95.66	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).